glp-1 news november 2025 supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – GLP-1 Pipeline Update: August 2025

DIM and I3C enhance the effects of anti-estrogen treatments by acting on AhR-mediated transcription, changing the epigenetics of estrogen-responsive genes, and suppressing ER signalling (199)

Due to the breadth of this subject matter, we have limited this review focussing on triagonists, whereby some other promising gut hormone compounds, such as cagrilintide, reviewed elsewhere [10], are not discussed

Eating well on a GLP-1 isnt just about choosing healthy foods

International shipping varies per market

Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway